Alerts will be sent to your verified email
Verify EmailGRAUWEIL
Grauer & Weil (I)
|
UPL
|
Tatva Chintan Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
15.3 % | 12.62 % | 23.7 % |
5yr average Equity Multiplier
|
1.43 | 3.6 | 1.85 |
5yr Average Asset Turnover Ratio
|
0.95 | 0.52 | 0.86 |
5yr Avg Net Profit Margin
|
11.2 % | 6.74 % | 14.91 % |
Price to Book
|
4.89 | 1.73 | 3.6 |
P/E
|
26.93 | 0.0 | 87.29 |
5yr Avg Cash Conversion Cycle
|
24.62 Days | -56.93 Days | 141.97 Days |
Inventory Days
|
50.57 Days | 78.29 Days | 90.7 Days |
Days Receivable
|
52.87 Days | 95.0 Days | 60.72 Days |
Days Payable
|
82.08 Days | 229.19 Days | 78.36 Days |
5yr Average Interest Coverage Ratio
|
43.7 | 2.88 | 12.37 |
5yr Avg ROCE
|
19.27 % | 11.64 % | 25.2 % |
5yr Avg Operating Profit Margin
|
18.13 % | 20.36 % | 21.01 % |
5 yr average Debt to Equity
|
0.04 | 1.38 | 0.57 |
5yr CAGR Net Profit
|
12.08 % | 19.08 % | 17.24 % |
5yr Average Return on Assets
|
10.68 % | 3.57 % | 12.62 % |
Shareholdings
|
|||
Promoter Holding
|
69.05 % | 32.35 % | 72.02 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 4.39 % | -7.15 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 2.12 % | 9.42 % |
Grauer & Weil (I)
|
UPL
|
Tatva Chintan Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Capex
|
Capex
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|